Eljure LN, Alcocer SM, Conde OCE, Torres GE, Atoche DCE

Language: Spanish
References: 26
Page: 104-110
PDF size: 209.66 Kb.

ABSTRACT

Background: mycetoma is a chronic, inflammatory syndrome that results from traumatic inoculation of actinomycetes (actinomycetoma) or fungi (eumycetoma). Estimated prevalence in Mexico is 0.15 per 100 thousand inhabitants, with a total of 3 933 cases according to the last national casuistic in 2013.
Materials and methods: We performed an observational, descriptive, retrospective study at the Mycology Laboratory in Dermatological Center in Yucatan from 2001 to 2021. Descriptive statistics were applied.
Results: seventy cases were studied: actinomycetomas 91.44% and eumycetomas 8.58%, Nocardia was the most frequent causal agent, the trunk was the most affected corporal region in 60%, contrasting significantly with national and international literature.
Conclusions: improve training in first contact health personnel, and more laboratory infrastructure must be a priority in the Yucatan peninsula to help visualize the real magnitude of the problem.

REFERENCES

1. Dermatología Cosmética, Médica y QuirúrgicaDCMQ110Volumen 21 / Número 2 n abril-junio 2023 BIBLIOGRAFÍA 1. Arenas R y Torres-Guerrero E, Micología médica ilustrada, 6ªed., México, Mc Graw Hill Interamericana, 2019, pp. 141-64.

2. Bonifaz A, Tirado-Sánchez A, Calderón L, Saúl A, Araiza J, HernándezM et al., Mycetoma: experience of 482 cases in a singlecenter in Mexico, plos Negl Trop Dis 2014; 8(8):e3102.

3. Tilahun Zewdu F, Getahun Abdela S, Takarinda K, Mberu KamauE, Van Griensven J y Van Henten S, Mycetoma patients in Ethiopia:case series from Boru Meda Hospital, J Infect Dev Ctries2022; 16(8.1):41s-4.

4. Torres-Guerrero E y Niebla-Maldonado A, Mycetoma. Clinical andmicrobiological monograph, Sarrebruck, Scholars’ Press, 2015.

5. Samy AM, Van de Sande WWJ, Fahal AH y Peterson AT, Mappingthe potential risk of mycetoma infection in Sudan and SouthSudan using ecological niche modeling, plos Negl Trop Dis2014; 8(10):e3250.

6. who, Addressing the burden of mycetoma, 2016. Disponibleen: https://www.who.int/neglected_diseases/mediacentre/WHA_69.21_Eng.pdf?ua=1.

7. Kwizera R, Bongomin F, David B. Meya DB, Denning DW, FahalAH et al., Mycetoma in Uganda: a neglected tropical disease,plos Negl Trop Dis; 14(4):e0008240.

8. Emery D y Denning DW, The global distribution of actinomycetomaand eumycetoma, plos Negl Trop Dis; 14(9):e0008397.

9. Zijlstra EE, Van de Sande WW, Welsh O, Mahgoub ES, GoodfellowM y Fahal AH, Mycetoma: a unique neglected tropicaldisease, Lancet Infect Dis 2016; 16:100-12.

10. Van de Sande W, Fahal AH, Ahmed AS, Serrano JA, Bonifaz Ay Zijlstra E, Closing the mycetoma knowledge gap, Med Mycol2018; 56:s153-64.

11. López-Martínez R, Méndez-Tovar LJ, Bonifaz A, Arenas R, MayorgaJ, Welsh O, Vera Cabrera L, Padilla-Desgarennes MC,Contreras-Pérez C, Chávez G, Hernández Hernández F y Manzano-Gayosso P, Actualización de la epidemiología del micetomaen México. Revisión de 3 933 casos, Gac Med Mex 2013;149:586-92.

12. Cruz Correa OF, Vega Sánchez DC, Ramírez Hobak L y ArenasGuzmán R, Micetoma. Informe de 174 casos estudiados en 30años en el Hospital General Dr. Manuel Gea González de la Ciudadde México (1987-2017), dcmq 2018; 16(4):263-7.

13. Cárdenas de la Garza JA, Welsh O, Cuéllar-Barboza A, Suárez-Sánchez KP, Cruz Gómez LG, De la Cruz-Valadez E et al., Climate,soil type, and geographic distribution of actinomycetoma casesin Northeast Mexico: a cross-sectional study, plos One 2020;15(5):e0232556.

14. Hassan R, Deribe K, Fahal AH, Newport M y Bakhiet S., Clinicalepidemiological characteristics of mycetoma in EasternSennar locality, Sennar State, Sudan, plos Negl Trop Dis 2021;

15. 15(12):e0009847.15. Dubey N, Capoor MR, Hassan AS, Gupta A, Ramesh V, SharmaS, Singh A, Rudramurthy SM y Chakrabarti A, Epidemiologicalprofile and spectrum of neglected tropical disease eumycetomafrom Delhi, North India, Epidemiology and Infection 2019;147,e294:1-8.

16. Fahal A, Mahgoub ES, El Hasan AM et al., A new model formanagement of mycetoma in the Sudan, plos Negl Trop Dis2014; 8:e3271.

17. Nenoff P, Van de Sande WWJ, Fahal AH, Reinel D y Schöfer H,Eumycetoma and actinomycetoma: an update on causativeagents, epidemiology, pathogenesis, diagnostic and therapy,jeadv 2015. doi: 10.1111/jdv.13008.

18. Hassan R, Simpson H, Cano J, Bakhiet S, Ganawa E, Argow D,Newport MJ, Deribe K y Fahal AH, Modelling the spatial distributionof mycetoma in Sudan, Trans R Soc Trop Med Hyg 2021;115:1144-52.

19. Kresch-Tronik N, Carrillo-Casas EM, Arenas R, Atoche C,Ochoa-Carrera LA, Xicohtencatl-Cortés J, Manjarrez-HernándezA y Hernández-Castro R, Nocardia harenae, an uncommon causativeorganism of mycetoma: report on two patients, Journalof Medical Microbiology 2012; 61:1153-5.

20. Seo JP y Lee SD, Nocardia harenae sp. nov., an actinomyceteisolated from beach sand, Int J Syst Evol Microbiol 2006;56:2203-7.

21. Kresch-Tronik NS, Carrillo-Casas EM, Arenas R, Atoche C, DelRío-Ávila C, Ochoa-Carrera LA, Xicohtencatl-Cortés J, Leyva-Leyva M y Hernández-Castro R, First case of mycetoma associatedwith Nocardia takedensis (Letters to the Editor), Int JDermatol 2012; 135-6.

22. Estrada R, Chávez-López G, Estrada-Chávez G y Hay R. Mycetomaand the Community Dermatology Program, Mexico, Trans RSoc Trop Med Hyg 2021; 115:383-6.

23. Atoche-Diéguez CE, Torres-Guerrero E, López-González R y ArenasR, Panorama epidemiológico de la cromoblastomicosis enel Centro Dermatológico de Yucatán, Dermatol Rev Mex 2016;60(6):459-6.

24. http://www.cuentame.inegi.org.mx/monografias/informacion/yuc/territorio/clima.

25. Morales JJ, La península que surgió del mar, 1ª ed., México,pp. 10-6.

26. Ganawa ETS, Bushara MA, Musa AEA, Bakhiet SM y Fahal AH,Mycetoma spatial geographical distribution in the Eastern Sennarlocality, Sennar State, Sudan, Trans R Soc Trop Med Hyg2021; 115:375-82.